Montana is taking a bold step in the ongoing national debate over vaccine safety and medical autonomy. The state legislature is set to vote on a bill that would ban mRNA vaccines, a move that ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

BOISE — Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in ...

Moderna, Inc. (NASDAQ:MRNA – Get Free Report) was the recipient of unusually large options trading on Tuesday. Stock investors bought 179,268 call options on the company. This represents an increase ...

Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote.

Dr Jay Bhattacharya is one of the signatories of an online petition that claims there is a 'casual link' between the mRNA ...

Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...

Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...

The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...

Since 2021, experts have seen bird flu — also called H5 influenza or highly pathogenic avian influenza (HPAI) — spreading ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the 3% gain from Friday when it reported fourth-quarter 2024 ...

University of Queensland researchers have for the first time introduced genetic material into plants via their roots, opening ...